Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation
By: Amandeep Kaur, Subheet Jain and Ashok Tiwary
Open Access
|Mar 2008References
- M. S. Meltzer, D. R. Skillman, P. J. Gomatos, D. C. Kalter and H. C. Gendelman, Role of mononuclear phagocytosis in the pathogenesis of human immunodeficiency virus infection,(1990)169-194; DOI: 10.1146/annurev.iy.08.040190.001125.
- S. Aquaro, R. Calio, J. Balzarini, M. C. Bellocchi, E. Garaci and C. F. Perno, Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir,(2002) 209-225; DOI: 10.1016/S0166-3542(02)00052-9.
- C. Oussoren, M. Magnani, A. Fraternale, A. Casabianca, L. Chiarantini, R. Ingebrigsten, W. J. M. Underberg and G. Strome, Liposomes as carrier of the antiretroviral agent dideoxycytidine-5'-triphosphate,(1999) 261-270; DOI: 10.1016/S0378-5173(99)00016-2.
- V. Schafer, H. V. Briesen, H. Rubsamen-Waigmann, A. M. Steffan, C. Royer and J. Kreuter, Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages,(1994) 261-269; DOI: 10.3109/02652049409040455.
- Z. Cui, C. H. Hsu and R. J. Mumper, Physical characterization and macrophage cell uptake of mannan-coated nanoparticles,(2003) 689-700; DOI: 10.1081/DDC-120021318.
- F. Ahsan, I. P. Rivas, M. A. Khan and A. I. T. Suarez, Targeting of macrophage: role of physicochemical properties of particulate carriers-liposomes and microsphere on the phagocytosis by macrophages,(2002) 29-40; DOI: 10.1016/S0168-3659(01)00549-1.
- J. Kreuter, Nanoparticulate system for brain delivery of drugs,(2001) 65-81; DOI: 10.1016/S0169-409X(00)00122-8.
- M. S. Wadhwa and K. G. Rice, Receptor mediated glycotargeting,(2003) 255-268; DOI: 10.1080/10611860310001636557.
- J. Shao and J. K. H. Ma, Characterization of mannosylphospholipid liposome system for drug targeting to alveolar macrophages,(1997) 43-48.
- Y. Gabr, N. Assem, A. Micheal and L. Fahmy, Evaluation studies on oxypolygelatin and degraded gelatin as plasma volume expanders,(1996) 763-766.
- R. Yarchoan, H. Mitsuya, R. V. Thomas, J. M. Pluda, N. R. Hartman and C. F. Perno, In vivo activity against HIV and favorable toxicity profile of 2'3'-dideoxyinosine,(1989) 412-417.
- T. P. Cooley, M. L. Kunches, C. A. Saunders, C. J. Perkins, S. L. Kelley, C. McLaren, R. P. McCaffrey and H. A Liebman, Treatment of AIDS and AIDS related complex with 2'3'-dideoxyinosine given once daily,(1990) S552-S560.
- C. J. Coester, K. Langer, H. Von Briesen and J. Kreuter, Gelatin nanoparticles by two step desolvation - A new preparation method, surface modification and cell uptake,(2000) 187-193; DOI: 10.1080/026520400288427.
- J. Vandervoort and A. Ludwig, Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use,(2004) 251-261; DOI: 10.1016/S0939-6411(03)00187-5.
- E. Rebasamen, W. Goldinger, W. Scheirer, O. W. Merten and G. E. Palfe,(Eds. R. Spier and W. Hennessen), Vol., ESACT, Basel 1987, pp. 557-583.
- V. F. Courtney, R. C. Brundage, R. P. Remmel, L. M. Page, D. Weller, N. R. Calles, C. Simon and M. W. Kline, Pharmacologic characteristic of indinavir, didanosine and stavudine in human immunodeficiency virus-infected children receiving combination therapy,(2000) 1029-1034.
- S. Jain, R. Sapre, A. K. Tiwary and N. K. Jain, Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization and performance evaluation, AAPS(2005) E513-E522; DOI: 10.1208/pt060364.
- S. Kaul, W. C. Shyu, U. A. Shukla, K. A. Dandekar and R. H. Barbhaiya, Pharmacologic characteristic of indinavir, didanosine and stavudine in human immunodeficiency Virus-Infected children receiving combination therapy,(1993) 447-453.
- E. Mukherji, N. J. Millenbaugh and J. L. S. Au, Percutaneous absorption of 2',3'-dideoxyinosine in rats,(1994) 809-815.
- O. Bekers, J. H. Beijnen, M. J. T. Klein Tank, D. M. Burger, P. I. Meenhorst, A. J. P. F. Lombarts and W. J. M. Underberg, 2',3'-dideoxyinosine (ddI): Its chemical stability and cyclodextrin complexation in aqueous media,(1993) 489-493; DOI: 10.1016/0731-7085(93)80162-T.
- P. T. Tayade and R. D. Kale, Encapsulation of water-insoluble drug by a cross-linking technique: Effect of process and formulation variables on encapsulation efficiency, particle size, anddissolution rate, AAPS(2004); DOI: 10.1208/ps060112.
- C. Sanchez-Lafuente, A. M. Rabasco, J. Alvarez-Fuentes and M. Fernandez-Arevalo, Eudragit® RS-PM and Ethocel® 100 premium: influence over the behavior of didanosine inert matrix system,(2002) 649-656; DOI: 10.1016/S0014-827X(02)01240-5.
- V. Apostolopoulos and I. F. McKenzie, Role of the mannose receptor in the immune response,(2001) 469-474; DOI:10.2174/1566524013363645.
- C. A. Hoppe and Y. C. Lee, The binding and processing of mannose-bovine serum albumin derivatives by rabbit alveolar macrophages. Effect of the sugar density,(1983) 14193-14199.
- M. Velinova, N. Read, C. Kirby and G. Gregoriadis, Morphological observation on the fate of liposomes in the regional lymph nodes after footpad injection into rats,(1996) 207-215; DOI: 10.1016/0005-2760(95)00208-1.
Language: English, Croatian
Page range: 61 - 74
Published on: Mar 12, 2008
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2008 Amandeep Kaur, Subheet Jain, Ashok Tiwary, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.